Vanberra Signal
Free trial

Auransa

Curated by Signal

Developer of AI-based precision medicines for cancer

Health Technologyauransa.com

Overview

Auransa has developed precision medicines for cancer. The company lead product candidate used against hepatocellular carcinoma is in pre-clinical trials. They have developed an AI-driven platform for discovering targets, mechanisms of action, and therapies. Other products of the company used against acute myeloid leukemia, breast cancer, multiple myeloma, prostate cancer, infection, and inflammatory diseases are still in the discovery phase.

Key facts

Founded
2014
Headquarters
Palo Alto, United States
Stage
Sign up to view
Industry
Health Technology

Business model

3 products and services
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Pulse for Travelers

    Provider of a social networking platform for medical healthcare travelers

    Health TechnologyOmaha, United States

  • Crescendo

    Provider of a mobile app for tracking athletic performance and progress

    Health TechnologyUnited States

About Auransa

What does Auransa do?

Auransa has developed precision medicines for cancer.

Where is Auransa headquartered?

Auransa is headquartered in Palo Alto, United States.

When was Auransa founded?

Auransa was founded in 2014.

Which sector is Auransa in?

Auransa operates in Health Technology.

Who are Auransa's competitors?

Companies similar to Auransa include Pulse for Travelers, Crescendo, and Discount Contact Lenses.